Manufacturing & Packaging

A conversation with Vin Colicchio, vice president, supply chain and external manufacturing, Dr. Reddy’s Laboratories

Newly licensed US facility to increase availability of company's influenza vaccine

Health insurer Anthem joins BCBS organizations to form CivicaScript

Commercial-stage company will work with cell therapy partners to advance late-stage clinical programs

Will help UK consortium advance oral solid dosage medicines production

Site expected to begin operations by January 2022

Company's PA campus will be growing to 300,000 square feet

CDMO's Germany facility will supply starting material as part of manufacturing deal

New facilities will allow Spain CDMO to ramp up its production capacity for cell and gene therapy sector

Expansion will total over 50,000 square feet at company's existing Spokane site

CDMO’s North Carolina production site will be engineering Covid-19 vaccine doses

Production of the key component of gene therapies and certain vaccines for Covid-19 hampered by insufficient manufacturing capacity, according to GlobalData

Vaccine maker will use CDMO’s South Korean facilities to support additional Covid doses

Expansion features a new lyophilization center to meet point-of-care demand

Facility will house 44,000 square feet of clinical and commercial cGMP, and other tech services

Expansion establishes role it plays in the oncology sector, company suggests

Pauses per manufacturer due to label-printing problems occur just under six times a year, on average, report finds

New sterile production area at Italy facility aims to benefit biologics manufacturing, such as BSL vaccines

Company also plans to design a manufacturing site for future mRNA vaccines and therapeutics

Will use new facility in Belgium for commercial production of plasmid DNA

CDMO giant invests nearly $1 billion in Switzerland and New Hampshire sites

Renovation more than doubles size of Massachusetts facility

Company also says that drug substance manufacturing can double at its facilities

As India Covid cases continue to spike, biotech company will provide resources to help boost local manufacturing

Partnership will begin with tackling Friedreich’s ataxia, then extend to other gene transfer therapies